StockData
Entrada Therapeutics, Inc. logo

Entrada Therapeutics, Inc. (TRDA) stock

TRDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$4.96−0.04 (-0.80%)

Close on Nov 17, 2026Market cap $193.13MP/E –Yield –

Entrada Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Entrada Therapeutics's market cap was $211.82M on Nov 11, 2026, against $392.51M a year earlier. Over the last 5 years it ranged from $17.13M to $743.90M, with a median of $400.28M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$211.82M-46.1%
2025Dec 31, 2025$392.89M-39.2%
2024Dec 31, 2024$646.65M+28.5%
2023Dec 29, 2023$503.10M+18.8%
2022Dec 30, 2022$423.52M+1498.3%
2021Dec 31, 2021$26.50M–

More Entrada Therapeutics figures

See a number that looks wrong?